Active ingredient
Methohexital
3 finished FDA listings contain Methohexital as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- METHOHEXITAL, METHOHEXITAL SODIUM
- Dosage forms
- Injection, Injection, Powder, Lyophilized, For Solution
- Routes
- Intramuscular, Intravenous, Rectal
- Manufacturers / labelers
- 3
- Strengths listed
- 500 mg/1 · 500 mg/500mg
- Brand names in FDA listings
- Brevital Sodium
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 6847
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 011559 | PH HEALTH | 1960-06-27 | 1 |
| ANDA 215488 | ONESOURCE SPECIALTY | 2024-10-03 | 2 |
Official labeling on DailyMed
- METHOHEXITAL SODIUM INJECTION [HERITAGE PHARMACEUTICALS INC. D/B/A AVET PHARMACEUTICALS INC.] · version 3 · 2026-07-29
- BREVITAL SODIUM (METHOHEXITAL SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PAR HEALTH USA, LLC] · version 18 · 2026-05-20
- METHOHEXITAL SODIUM INJECTION [ONESOURCE SPECIALTY PHARMA LIMITED] · version 5 · 2026-02-23
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.